This grant is for supporting fundamental and practical research dedicated to understanding and enhancing the durability of immune responses to prospective HIV vaccine candidates. The funding initiative seeks to advance scientific knowledge by exploring the mechanisms that govern long-lasting immunity. Investigators are encouraged to propose projects that delve into basic immunology, virology, and vaccine development, alongside applied studies focused on translating discoveries into improved vaccine strategies. The ultimate aim is to facilitate the engineering of robust and enduring protective immunity against HIV, thereby contributing to the development of highly effective and sustained vaccine solutions crucial for global HIV prevention efforts.
Opportunity ID: 353797
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-24-025 |
Funding Opportunity Title: | Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 25, 2024 |
Last Updated Date: | Apr 25, 2024 |
Original Closing Date for Applications: | Oct 09, 2024 |
Current Closing Date for Applications: | Oct 09, 2024 |
Archive Date: | Nov 14, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | $750,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education Special district governments For profit organizations other than small businesses Private institutions of higher education Small businesses Native American tribal governments (Federally recognized) City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities State governments Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to support basic and applied research to understand and improve durable immune responses to candidate HIV vaccines. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-025.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 353797 Full Announcement-RFA-AI-24-025 -> RFA-AI-24-025-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00286080 | Sep 09, 2024 | Oct 09, 2024 | View |
Package 1
Mandatory forms
353797 RR_SF424_5_0-5.0.pdf
353797 PHS398_CoverPageSupplement_5_0-5.0.pdf
353797 RR_OtherProjectInfo_1_4-1.4.pdf
353797 PerformanceSite_4_0-4.0.pdf
353797 RR_KeyPersonExpanded_4_0-4.0.pdf
353797 PHS398_ResearchPlan_5_0-5.0.pdf
353797 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353797 RR_Budget_3_0-3.0.pdf
353797 RR_SubawardBudget30_3_0-3.0.pdf
353797 PHS398_ModularBudget_1_2-1.2.pdf
353797 PHS_AssignmentRequestForm_3_0-3.0.pdf